跳至主要内容
临床试验/NCT02609100
NCT02609100终止不适用

Video Capsule Endoscopy Versus Colonoscopy in Patients With Melena and Negative Upper Endoscopy: A Randomized Controlled Trial

Washington University School of Medicine1 个研究点 分布在 1 个国家目标入组 4 人开始时间: 2015年11月1日最近更新:
适应症
干预措施

试验速览

阶段
不适用
状态
终止
入组人数
4
试验地点
1
主要终点
Number of Participants With Clinically Significant Findings Defined as Lesions Considered to Have a High Potential for Bleeding to Participants With no Significant Findings From Video Capsule Endoscopy

研究概览

简要总结

Acute gastrointestinal bleeding is a common medical problem. When patients with gastrointestinal bleeding present with melena (dark, tarry stool) the blood loss is usually originating in the upper gastrointestinal tract (esophagus, stomach or duodenum) and first step in evaluating the patient is an upper endoscopy; which allows direct visualization of the esophagus, stomach and duodenum. However, the cause of bleeding is located in the small bowel or colon in 20-30% of patients who present with melena. Traditionally colonoscopy has been the next test preformed if upper endoscopy does not identify the cause of melena/ gastrointestinal bleeding, however less than 25% of patients who present with melena have bleeding originating in the colon, and the remainder of patients have bleeding originating in the small intestine, which can only be fully evaluated with video capsule endoscopy (a pill camera which is swallowed and takes pictures while it travels thought the small bowel and colon). Currently patients only undergo video capsule endoscopy if colonoscopy does not identify the cause of bleeding. The investigators are preforming a randomized study which seeks to determine if colonoscopy or video capsule endoscopy is a better way to identify the cause of gastrointestinal bleeding in patients who present with melena and have normal findings on upper endoscopy. To do this the investigators will enroll patients who present with melena prior to their upper endoscopy and if the cause of bleeding is not identified at that time patients will be randomized to video capsule endoscopy (with the capsule being placed into the small bowel during the upper endoscopy) or next day colonoscopy.

研究设计

研究类型
Interventional
分配方式
Randomized
干预模型
Parallel
主要目的
Diagnostic
盲法
None

入排标准

年龄范围
18 Years 至 —(Adult, Older Adult)
性别
All
接受健康志愿者
否

入选标准

  • •Inpatients >18 years of age presenting with lower gastrointestinal bleeding and have melenic stool

排除标准

  • •Unable to provide written informed consent
  • •A probable bleeding source is identified on upper endoscopy
  • •Pregnancy or lactation
  • •Swallowing Disorder
  • •Unable to tolerate sedation or anesthesia due to medical co-morbidities
  • •Uncorrected coagulopathy (platelet count <50,000, INR> 2, PTT> 2x upper limit of normal)
  • •Known or suspected gastrointestinal obstruction or stricture
  • •Cardiac pacemaker or other implanted electromedical device
  • •Contraindication to bowel preparation

研究组 & 干预措施

Video Capsule Endoscopy

Active Comparator

Randomization arm one is to video capsule endoscopy (VCE) a non-invasive procedure in which a patient swallows a disposable 1.0 X 2.5 cm 'pill' containing a camera electronically linked to equipment outside the patient which records images as it passes from the esophagus through the entire tract and is excreted in feces. It images the small intestine in areas beyond the reach of upper GI endoscopy and the terminal ileum and is similarly beyond the reach of colonoscopy. Its greatest use is in identifying points of bleeding and ulcers.

干预措施: Video Capsule Endoscopy (Procedure)

Video Capsule Endoscopy

Active Comparator

Randomization arm one is to video capsule endoscopy (VCE) a non-invasive procedure in which a patient swallows a disposable 1.0 X 2.5 cm 'pill' containing a camera electronically linked to equipment outside the patient which records images as it passes from the esophagus through the entire tract and is excreted in feces. It images the small intestine in areas beyond the reach of upper GI endoscopy and the terminal ileum and is similarly beyond the reach of colonoscopy. Its greatest use is in identifying points of bleeding and ulcers.

干预措施: 1.0 X 2.5 cm 'pill' containing a camera (Device)

Next Day Colonoscopy

Active Comparator

Randomization arm two is to colonoscopy, a test that allows the doctor to look at the inner lining of the large intestine (rectum and colon). He or she uses a thin, flexible tube called a colonoscope to look at the colon.

干预措施: Colonoscopy (Procedure)

结局指标

主要结局

Number of Participants With Clinically Significant Findings Defined as Lesions Considered to Have a High Potential for Bleeding to Participants With no Significant Findings From Video Capsule Endoscopy

时间窗: Up to twenty four hours

Video Capsule Endoscopy identifies clinically significant lesions defined as lesions considered to have high potential for bleeding, such as a large ulceration, tumor or typical angiomata

Number of Participants With Clinically Significant Findings Defined as Lesions Considered to Have a High Potential for Bleeding to Participants With no Significant Findings From Colonoscopy

时间窗: Up to one hour

Colonoscopy identifies clinically significant lesions defined as lesions considered to have high potential for bleeding, such as a large ulceration, tumor or typical angiomata

次要结局

  • Therapeutic Yield of Colonoscopy(Up to 7 days)
  • Number of Blood Units Transfused(Up to 60 days)
  • Number of Diagnostic Studies Performed for Evaluation of Gastrointestinal Bleeding(Up to 60 days)
  • Duration of Hospital Stay(Up to 60 days)
  • Procedure Related Adverse Events(Up to 60 days)
  • Therapeutic Yield of Video Capsule Endoscopy(Up to 7 days)

研究者

申办方类型
Other
责任方
Sponsor

研究点 (1)

Loading locations...

相似试验